Day trading IdeaPlease note:
- I'm just sharing my view. its not a recommendation for buying or selling.
- penny stocks moves most of the times are " pump n dump". don't chase them, and you must have an exit plan.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−28.15 M ILS
2.74 M ILS
2.04 B
About CAN FITE BIO
Sector
CEO
Motti Farbstein
Headquarters
Ramat Gan
Website
Founded
1994
ISIN
IL0010944739
FIGI
BBG000KVYG87
Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.
CANF: Another small biopharma to consider.UP strongly on big volume today on very positive news.
Expect volatility. High risk.
Process your way.
$CANF ready for breakout? 12rr ideaif next 15m candle closes above 3.22 will be bullish on it
Now or never, This is a key level. Gap will fill if trendline rejects. need a close above 3.22
$CANF Signs $42.7 Million Out-Licensing Deal with EwopharmaCan-Fite Signs $42.7 Million Out-Licensing Deal with Ewopharma
Swiss Ewopharma to market Piclidenoson and Namodenoson in Central Eastern Europe (CEE)
$2.25 million upfront payment with an additional $40.45 million for regulatory & sales milestones and 17.5% royalties are included
finance.yahoo.co
$CANF Can Fite Biopharma Long Into earnings Potential trade into earnings with top of channel as a longer term target.
Golden cross imminent
$CANF Can-Fite BioPharma Ltd. 20% upside Can-Fite BioPharma Ltd. engages in the development of drugs for cancer and inflammatory diseases. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.
CAN FITE BIOPHARMA reports positive data from Phase-II study of CAN FITE BIOPHARMA (NYSE:CANF) proliferated 11.24% since last week. The company, on June 30 announced its final data analysis of the NASH study, which is in Phase-II. The company announced that it observed positive data, where there was sustained reduction and highly efficient too, in the volume of
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CANF is 2.8 ILA — it hasn't changed in the past 24 hours. Watch CAN FITE BIO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TASE exchange CAN FITE BIO stocks are traded under the ticker CANF.
CANF stock hasn't changed in a week, the month change is a −6.67% fall, over the last year CAN FITE BIO has showed a 7.69% increase.
We've gathered analysts' opinions on CAN FITE BIO future price: according to them, CANF price has a max estimate of 22.51 ILA and a min estimate of 12.50 ILA. Watch CANF chart and read a more detailed CAN FITE BIO stock forecast: see what analysts think of CAN FITE BIO and suggest that you do with its stocks.
CANF reached its all-time high on Mar 23, 2015 with the price of 1,163.0 ILA, and its all-time low was 2.1 ILA and was reached on Apr 13, 2023. View more price dynamics on CANF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CANF stock is 3.70% volatile and has beta coefficient of 0.37. Track CAN FITE BIO stock price on the chart and check out the list of the most volatile stocks — is CAN FITE BIO there?
Today CAN FITE BIO has the market capitalization of 57.23 M, it has decreased by −3.45% over the last week.
Yes, you can track CAN FITE BIO financials in yearly and quarterly reports right on TradingView.
CAN FITE BIO is going to release the next earnings report on Nov 29, 2024. Keep track of upcoming events with our Earnings Calendar.
CANF earnings for the last quarter are 0.00 ILA per share, whereas the estimation was 0.00 ILA resulting in a −200.27% surprise. The estimated earnings for the next quarter are 0.00 ILA per share. See more details about CAN FITE BIO earnings.
CAN FITE BIO revenue for the last quarter amounts to 377.91 K ILA, despite the estimated figure of 1.13 M ILA. In the next quarter, revenue is expected to reach 559.74 K ILA.
No, CANF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 13, 2024, the company has 5.00 employees. See our rating of the largest employees — is CAN FITE BIO on this list?
Like other stocks, CANF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CAN FITE BIO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CAN FITE BIO technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CAN FITE BIO stock shows the sell signal. See more of CAN FITE BIO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.